Structural Biology and Crystallization Communications
Expression, purification, crystallization and preliminary X-ray structure analysis of Vibrio cholerae uridine phosphorylase in complex with thymidine A high-resolution structure of the complex of Vibrio cholerae uridine phosphorylase (VchUPh) with its physiological ligand thymidine is important in order to determine the mechanism of the substrate specificity of the enzyme and for the rational design of pharmacological modulators. Here, the expression and purification of VchUPh and the crystallization of its complex with thymidine are reported. Conditions for crystallization were determined with an automated Cartesian Dispensing System using The Classics, MbClass and MbClass II Suites crystallization kits. Crystals of the VchUPh-thymidine complex (of dimensions $200-350 mm) were grown by the sitting-drop vapour-diffusion method in $7 d at 291 K. The crystallization solution consisted of 1.5 ml VchUPh (15 mg ml À1 ), 1 ml 0.1 M thymidine and 1. ; the corresponding solvent content was 43.74%.
Introduction
Uridine phosphorylase (UPh; EC 2.4.2.3) is a major enzyme that catalyzes the phosphorylation of pyrimidine nucleotides (Pizzorno et al., 1998 (Pizzorno et al., , 2002 Schwartz et al., 1985) . The activity of UPh is known to be vital in some pathogenic bacteria and protozoa (Jimé nez et al., 1989; Lee et al., 1988) . In previous publications, we have reported structures of UPh from Salmonella typhimurium with physiological ligands and pharmacological inhibitors (Dontsova et al., 2004 (Dontsova et al., , 2005 Timofeev et al., 2007; Lashkov et al., 2009 Lashkov et al., , 2010 Lashkov et al., , 2012 . However, the diffraction resolution of complexes of bacterial UPh with thymidine does not allow conclusions to be drawn regarding the details of enzyme-ligand binding. Based on structural and biochemical data on Escherichia coli UPh (EcUPh), a mechanism of substrate specificity has been proposed (Caradoc-Davies et al., 2004 ; PDB entry 1rxu; 3.1 Å resolution). The higher affinity of EcUPh for uridine compared with that for thymidine has been attributed to the formation of hydrogen bonds between the hydroxyl group at the 2 0 position of the ribose ring of uridine and the carboxy group of the Glu198 side chain in the active centre of the enzyme. Thymidine lacks the hydroxyl group at the 2 0 position of the ribose ring. Furthermore, a lower affinity of EcUPh for thymidine than for uridine may also be explained by steric hindrance caused by the methyl group at position 5 of thymidine (Caradoc-Davies et al., 2004) . However, even bulkier (compared with the methyl group) hydrophobic substituents at position 5 of the pyrimidine ring do not hamper the binding of ligands to EcUPh (Bu et al., 2005; Drabikowska, Lissowska, Draminski et al., 1987; Drabikowska, Lissowska, Veres et al., 1987; Niedzwicki et al., 1982; Pizzorno et al., 1998; Veres et al., 1987) . Overall, it is difficult to unequivocally predict the interaction of individual chemical groups with EcUPh on the basis of the structure of the EcUPh-thymidine complex refined at 3.1 Å resolution (Caradoc-Davies et al., 2004) . A higher resolution structure of the complex is needed. From the biomedical viewpoint, data on the three-dimensional structures of UPh-thymidine complexes will be beneficial for the design of novel pyrimidine-based drugs.
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In this study, we analyzed the structure of the complex formed by Vibrio cholerae UPh (VchUPh) with thymidine.
Expression
2.1. Cloning the V. cholerae udp gene into pUC19 vector
The primers 5 0 -CCGGATCCGCGCCACATCAAGTGGCGC-3 0 (forward) and 5 0 -GGGGAATTCAAGTAGGAAGGGGATAGA-GG-3 0 (reverse) were selected on the basis of the complete sequence of the V. cholerae genome (GenBank accession No. CAB94933.1). These primers were utilized for PCR amplification of the udp gene coding for VchUPh using V. cholerae chromosomal DNA as a template. The PCR product included regulatory and structural regions of the udp gene and EcoRI and BamHI recognition sites (italicized). The amplified DNA fragment was eluted from agarose gel using GeneClean (Fermentas, Lithuania), digested with EcoRI and BamHI and cloned into a multiple-copy vector pUC19 (Ap r , lacZ M15, pBR322 ori). The resulting construct pMZ21 (pUC19 with a 1030 bp EcoRI-BamHI fragment of the V. cholerae udp gene) was used for transformation of E. coli AM201 strain (genotype supE hsdD5 thi Á(lac-proAB) ÁmetE-udp/F 0 [traD36 proAB (+) lacI (q) lacZ ÁM15]) followed by selection of Amp R Udp + clones (Zolotukhina et al., 2003) . After selection of the E. coli transformants, the plasmid DNA was isolated and sequenced. The DNA encoded by pMZ21 carried one full reading frame for a 253-amino-acid protein with a predicted molecular mass of 27.5 kDa (Zolotukhina et al., 2003) .
Expression of the udp gene in E. coli
E. coli strain AM201 containing the pMZ21 plasmid was grown overnight in enriched Luria broth supplemented with 100 mg ml À1 ampicillin. Cells were pelleted, resuspended in buffer (62.5 mM Tris-HCl pH 6.8, 5% glycerol, 2% -mercaptoethanol, 0.1% sodium dodecyl sulfate) and then boiled for 10 min. Proteins were resolved by SDS-PAGE. Proteins of the E. coli AM201 strain carrying an empty pUC19 plasmid were used as a control. An $28 kDa band corresponding to the udp gene product was detectable (Fig. 1) . The molecular mass of the expressed protein was close to the predicted value (27.5 kDa) calculated on the basis of udp gene sequencing (Zolotukhina et al., 2003) .
Purification
To purify VchUPh, E. coli AM201 strain carrying the pMZ21 plasmid was grown in Luria broth with 100 mg ml À1 ampicillin on a shaker (250 rev min
À1
; 310 K) for 12 h. The bacterial cells were pelleted. The yield was 9 g per 1.5 l of growth medium. The cells were resuspended in 50 mM Tris-HCl buffer pH 7.5, 5 mM -mercaptoethanol, 0.3 mM phenylmethanesulfonyl fluoride (PMSF) and disrupted using ultrasound. After centrifugation, the supernatant was diluted with a 10%(v/v) solution of Polymin P (pH 6.0) and the mixture was stirred for 12 h at 277 K. The pellet was resuspended in a buffer consisting of 50 mM Tris-HCl pH 7.5, 2 M ammonium sulfate, 5 mM -mercaptoethanol, 0.3 mM PMSF and incubated for 12 h at 277 K. The pellet was concentrated by low-speed centrifugation, resuspended in 50 mM Tris-HCl pH 7.5, 2 M ammonium sulfate and loaded onto a ButylSepharose column (Amersham Pharmacia Biotech) equilibrated with the same buffer. The protein was eluted with a gradient of ammonium sulfate from 2 to 0 M at a flow rate of 0.5 ml min À1 . Fractions pooled after column purification were analyzed by SDS-PAGE under denaturing conditions (Fig. 2) . In the second step of protein purification, the pooled fractions containing VchUPh were dialyzed against 50 mM Tris-HCl pH 7.5, 20 mM NaCl and loaded onto a QSepharose column equilibrated with the same buffer. The enzyme was eluted using an NaCl gradient from 20 mM to 1 M at a flow rate of 1 ml min À1 . The fractions were pooled, resolved on SDS-PAGE under denaturing conditions (Fig. 2) , centrifuged, dialyzed against buffer (20 mM Tris-HCl pH 7.5, 20 mM NaCl) and concentrated to 15 mg ml À1 in the same buffer solution.
Crystallization
The conditions for crystallization of the complexes of VchUPh with thymidine were determined using an automated Cartesian Dispensing System (Genomic Solutions; http://www.digilabglobal.com) using The Classics, MbClass and MbClass II Suites crystallization kits (Qiagen). Crystals of the VchUPh-thymidine complex with dimensions of $200-350 mm were grown in 7 d using the sitting-drop vapour-diffusion method at 291 K (Fig. 3) . The crystallization mixture consisted of 1.5 ml protein solution (15 mg ml À1 ), 1.5 ml reservoir solution and 1 ml 0. 
X-ray data collection and preliminary X-ray structure analysis
The crystal was directly flash-cooled in a stream of nitrogen gas at 100 K using an Oxford Cryosystems cooling device. Prior to freezing in liquid nitrogen, the crystal was transferred into a cryoprotectant solution [0.2 M MgCl 2 .6H 2 O, 15%(w/v) PEG 4000, 40%(w/v) PEG 400 in 0.1 M Tris-HCl pH 8.5]. X-ray diffraction data were collected from the VchUPh-thymidine complex crystal on the X13 Consortium Beamline at DORIS, DESY, Hamburg, Germany using a MAR CCD 165 detector (MAR Research, Germany) with a crystal-to-detector distance of 201 mm. The wavelength was 0.801 Å and each frame was exposed for 30 s. All data were indexed, merged and processed using XDS (Kabsch, 2010) , POINTLESS and SCALA . The data statistics are summarized in Table 1 .
For phasing, molecular replacement was applied using the program Phaser (McCoy et al., 2007) , with the structure of VchUPh (PDB entry 3o6v; Center for Structural Genomics of Infectious Diseases, unpublished work) as a model after the removal of all ligands including water molecules.
The best solution was found for three homodimers in the asymmetric unit forming one hexameric molecule. The starting R factor was 0.395 and the overall correlation coefficient was 0.727. The Matthews coefficient was calculated to be 2.18 Å 3 Da À1 (Matthews, 1968) , corresponding to 43.74% solvent content (Table 1 ). The initial model was confirmed by rigid-body refinement with REFMAC (Murshudov et al., 2011) . The program Coot (Emsley & Cowtan, 2004; Emsley et al., 2010 ) was used to model the VchUPh-thymidine complex. Further refinement was performed using restrained refinement in REFMAC (Murshudov et al., 2011) . The structure of the VchUPh-thymidine complex was characterized by an R work of 0.2220 and an R free of 0.2888.
Analysis of difference electron-density maps calculated with coefficients (|F obs | À |F calc |) in Coot (Emsley & Cowtan, 2004; Emsley et al., 2010) identified the position of the thymidine molecule in the active centre of VchUPh (Fig. 4) . Refinement of the VchUPhthymidine complex is currently in progress and will be published elsewhere.
This initial report of the structure of the complex of VchUPh with its physiological ligand thymidine provides a structural basis for the prediction of the inhibitory potency of newly designed antagonists of this enzyme. 
Figure 4
The binding site of VchUPh complexed with thymidine (prepared using CCP4mg; McNicholas et al., 2011) . Difference electron-density maps around the ligands were calculated with coefficients (2|F obs | À |F calc |). Residues Glu196/I, Thr93/I, Arg222/I, Arg167/I, Gln165/I belong to subunit I and His7/II belongs to subunit II. Water and thymidine are labelled W and THM, respectively. electronic reprint
